Employers Grapple With Rising Health Care Costs And Fiduciary Concerns

Being an employer in 2025 is not for the faint of heart. Striking the right balance in providing competitive benefits that support and engage the workforce while navigating an environment of growing fiduciary risk and cost containment pressures is a major challenge.

“Most employers are at an intersection of a rapidly evolving economic, legislative and political landscape, and health care is a key component of this,” said Doug Hammond, CEO of the benefits consultant NFP. “As employers strive to ensure their employees have access to quality health care, they also appreciate the importance of minimizing the costs passed on to their workforce. This requires employers to be proactive and innovative in their approach.”

Even as health care costs continue to rise, employers remain committed to their benefits programs, with only 4% decreasing their health care spend this year and 43% increasing it, the 2025 NFP U.S. Benefits Trend Report found. Among other key trends.

  • Various pieces of health care transparency legislation have identified areas requiring employers to meet their fiduciary responsibilities, such as designing an evaluation process for selecting vendors to deploy their health and welfare benefits strategy.
  • Recent high-profile litigation has heightened awareness of fiduciary obligations in pharmacy benefit management. Employers now are seeking more sophisticated approaches to their PBMs, with 70% prioritizing the control of prescription drug spend. To help control pharmacy costs, employers are shifting toward independent benefit management, with 64% choosing either direct PBM carve outs or coalition participation.
  • As employers struggle to manage the complexities of leave requirements, more than 7 in 10 spend more than four hours on administration for each leave request. Tools such as technology-supported or outsourced leave management are growing in popularity to help employers remain compliant.
  • Many employers are expanding their mental health offerings, in part, through support for employees and their families across various life stages, from pediatric and dependent-children mental health services to increased offerings for the “sandwich generation” of caregivers.
  • Employers also are focused on physical and social wellbeing programs. The emergence of GLP-1 drugs has drastically shifted attention to comprehensive health and weight management initiatives. There is a particular emphasis on holistic wellness programs that emphasize sustainable lifestyle changes through nutrition, education and exercise. In addition, employers are looking to social wellbeing programs to strengthen workplace connections through approaches that support remote and in-office employees.

“To deliver solutions that meet employee needs, employers should allocate resources where they’ll have the greatest impact,” said Kim Bell, head of health and benefits for NFP. “A targeted approach focusing on comprehensive wellbeing can strengthen employee engagement, align organizational priorities and provide support across the entire workforce.”

 

Source Link

Recommended Articles

Schumer Announces Health Care Plan

Senate Minority Leader Chuck Schumer officially unveiled Democrats’ plan for a health care vote next week, saying Thursday on the chamber floor his caucus will propose extending soon-to-expire Affordable Care Act subsidies for three years. “This is the bill, a clean three-year extension of ACA tax credits, that Democrats will bring to the floor of ...

Read More

House Votes To Pass 5-Year Hospital At Home Extension, Sending Bill To The Senate

The House of Representatives unanimously voted to pass a bill Monday that extends the Medicare hospital at home program for five years. Hospital at home providers have been mired in uncertainty for years. Though Congress has repeatedly extended hospital at home flexibilities, it often only does so for a handful of months at a time. ...

Read More

Lobbyists Are Salivating For More Of Trump’s Drug Price Deals

Lobbyists for some of the world’s largest drug companies are parading a new pricing deal in the U.K. as a model the rest of Europe should emulate if it wants to keep drugmakers from bailing for America. To President Donald Trump and the lobbyists’ delight, British officials agreed to spend 25 percent more on new ...

Read More

Senate Barrels Toward Failure On Health Care

Senators have about a week before they’re set to vote on soon-to-expire Affordable Care Act subsidies. Most of them already believe the chances for a bipartisan breakthrough by then are roughly zero. There’s no clear momentum for any plan that would avoid a lapse in tax credits that could raise insurance premiums for 20 million ...

Read More
arrowcaret-downclosefacebook-squarehamburgerinstagram-squarelinkedin-squarepauseplaytwitter-squareyoutube-square